June 1, 2017
ASLAN Pharmaceuticals receives clinical trial authorisation to initiate pivotal study of varlitinib in gastric cancer
May 24, 2017
ASLAN Pharmaceuticals successfully concludes Initial Public Offering with Public Draw 29 times oversubscribed
May 18, 2017
New data on varlitinib published at 2017 Annual Meeting of American Society of Cancer Oncology (ASCO)
May 16, 2017
ASLAN Pharmaceuticals successfully completes share auction
May 14, 2017
ASLAN Pharmaceuticals strengthens Taiwan presence with new office move
May 8, 2017
ASLAN Pharmaceuticals announces launch of competitive auction on 10 May 2017
April 28, 2017
ASLAN Pharmaceuticals supports the launch of the first biliary tract cancer patient group in Taiwan
April 26, 2017
ASLAN Pharmaceuticals announces intention to launch an initial public offering on Taipei Exchange
April 24, 2017
ASLAN Pharmaceuticals initiates global pivotal study for varlitinib in biliary tract cancer